Infectious Disease Control
/C O R R E C T I O N -- Korean Ginseng Research Institute/
We are advised by the client that there are several changes in the release content. The complete, corrected version of the news release issued on 21-Oct-2021 by Korean Ginseng Research Institute over PR Newswire is as follows: Red Ginseng's possible Vaccine Adjuvant Effect gave out from Korean Gin...
2021-10-22 17:20
3466
/C O R R E C T I O N -- Korean Ginseng Research Institute/
In the news release, Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng, issued20-Oct-2021 by Korean Ginseng Research Institute over PR Newswire, we are advised by the company that the headline, should read "Korean Ginseng Research Institute A...
2021-10-22 16:28
4315
Educating children about good hygiene is key to helping reduce future health threats
LONDON, Oct. 22, 2021 /PRNewswire/ -- The COVID-19 pandemic has heightened awareness globally of the role that hygiene measures like handwashing can play in infection prevention. Handwashing at high-risk moments is a proven and cost-effective way of reducing common infections by up to 50%. Resea...
2021-10-22 14:01
2345
Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution
* With hygiene in sharp focus, industry support for Aero HygenX continues to grow * Chemical-free disinfection via UV-C light offers a safer work environment for staff and is gentler on aircraft interiors * A global problem requires global solutions: It is the intention of Aero HygenX to ...
2021-10-21 21:57
2207
INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives
Memorandum of Understanding builds on recent regulatory authorization from INVIMAto conduct INNOVATE Phase 3 trial for INO-4800, INOVIO's COVID-19 vaccine candidate,in Colombia Colombia authorization augments recent regulatory authorizations from Brazil, the Philippines and Mexico to commence it...
2021-10-21 20:00
2877
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has filed with the United States Patent & Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen va...
2021-10-20 21:24
4329
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference
* Statistically significant 133% faster time to COVID-19 clinical symptoms recovery versus standard of care (SOC)/best supportive care. * Statistically significant 114% faster time to reach EQ-5D-5L Q6 ≥ 90% versus SOC/best supportive care. * Statistically significant 57% faster time to norm...
2021-10-20 20:52
1804
Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources
Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today a comm...
2021-10-20 13:29
2054
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections
LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2021-10-19 09:00
1683
Novavax to Participate in World Vaccine Congress Europe
GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...
2021-10-16 04:39
4288
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine
2021-10-15 18:36
2931
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results.
* One-shot Sputnik Light is the first component of the Sputnik V vaccine, the world's first registered vaccine against coronavirus. Sputnik V pioneered the heterogeneous boosting approach (a "vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus seroty...
2021-10-15 05:26
2277
More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals
* Allied health experts call for more community-based care models to cope with COVID surge * 'Long COVID' shown to affect one in four people who catch the virus, leading to an increase in chronic disease sufferers and the need for more rehabilitation services. The UK now has two million cases...
2021-10-13 05:00
1679
Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease
DURHAM, N.C. and BEIJING, Oct. 9, 2021 /PRNewswire/ -- Brii Biosciences
2021-10-09 03:07
5443
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
TEL AVIV, Israel and RALEIGH, N.C., Oct. 4, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-10-04 21:24
10074
Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company's SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2021
DURHAM, N.C.and BEIJING, Oct. 4, 2021 /PRNewswire/ -- Brii Biosciences
2021-10-04 08:00
3397
Impact Credit Solutions and Bank Central Asia partner to offer financing to the Indonesian healthcare sector
SINGAPORE, Sept. 30, 2021 /PRNewswire/ -- Bank Central Asia (BCA), a leading Indonesian commercial bank, and Impact Credit Solutions (ICS) have partnered to offer affordable financing to the Indonesian healthcare sector during the COVID-19 pandemic. BCA has committed toparticipating in the US$40 ...
2021-09-30 09:00
2391
Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India
DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its newDNA/RNA Shield - DirectDetect™ reagent and col...
2021-09-28 14:57
2233
Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy
DURHAM, N.C. and BEIJING, Sept. 28, 2021 /PRNewswire/ -- Brii Biosciences
2021-09-28 08:00
3518
LEAD Horizon: How travelers in Austria gargle against the corona virus
Austrian success model with gold standard tests is possible worldwide VIENNA, Sept. 27, 2021 /PRNewswire/ -- Vienna got through the pandemic better in comparison to other European cities - thanks to a specially developed PCR test by the Austrian company LEAD Horizon, which is already used in 13 ...
2021-09-27 09:00
2424
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
